Benefit Plans | (7) Benefit Plans (a) Equity Incentive Plan The Company maintains a 2008 Equity Incentive Plan (the “2008 Plan”) and a 2014 Equity Incentive Plan (the “2014 Plan”) pursuant to which the Company has reserved shares of its common stock for issuance to its employees, directors and non-employee third parties. The 2014 Plan serves as the successor to the 2008 Plan and permits the granting of options to purchase common stock and other equity incentives at the discretion of the compensation committee of the Company’s board of directors. No new awards have been or will be issued under the 2008 Plan since the effective date of the 2014 Plan. Outstanding awards under the 2008 Plan continue to be subject to the terms and conditions of the 2008 Plan. The number of shares of common stock reserved for issuance under the 2014 Plan will increase automatically each calendar year, continuing through and including January 1, 2024 (the “Evergreen provision”). The number of shares added each year will be equal to the lesser of (a) four and five tenths percent (4.5%) of the number of shares of common stock of the Company issued and outstanding on the immediately preceding December 31, or (b) an amount determined by the Company’s board of directors. The Company’s board of directors determined that, effective January 1, 2018, it would increase the number of common shares in reserve for issuance under the 2014 Plan by 2,367 shares. As of March 31, 2018, the Company had 13,883 shares allocated to the plans, of which 3,848 shares were subject to outstanding options or awards. Generally, the Company issues previously unissued shares for the exercise of stock options or vesting of awards; however, shares previously subject to 2014 Plan grants or awards that are forfeited or net settled at exercise or release may be reissued to satisfy future issuances. The following table summarizes changes in the number of shares available for grant under the Company’s equity incentive plans during the nine months ended March 31, 2018: Number of Available for grant at July 1, 2017 8,227 January 1, 2018 Evergreen provision increase 2,367 RSUs granted (884) Shares withheld in settlement of taxes and/or exercise price 339 Forfeitures 45 Shares removed (59) Available for grant at March 31, 2018 10,035 Shares removed represents forfeitures of shares and shares withheld in settlement of taxes and/or payment of exercise price related to grants made under the 2008 Plan. As noted above, no new awards will be issued under the 2008 Plan. Stock-based compensation expense related to stock options, restricted stock units (“RSUs”), and the Employee Stock Purchase Plan (as described below) is included in the following line items in the accompanying unaudited consolidated statements of operations and comprehensive income: Three Months Ended March 31, Nine Months Ended March 31, 2017 2018 2017 2018 Cost of revenue – recurring $ 485 $ 728 $ 1,621 $ 2,084 Cost of revenue – non-recurring 363 358 1,031 1,107 Sales and marketing 1,672 1,537 4,880 5,680 Research and development 797 926 2,461 2,742 General and administrative 2,930 3,918 8,702 10,278 Total stock-based compensation expense $ 6,247 $ 7,467 $ 18,695 $ 21,891 In addition, the Company capitalized $540 and $550 of stock-based compensation expense in its capitalized internal-use software costs in the three months ended March 31, 2017 and 2018, respectively, and $1,412 and $1,454 in the nine months ended March 31, 2017 and 2018, respectively. Under the 2008 and 2014 Plans, the exercise price of each option cannot be less than the fair value of a share of common stock on the grant date. The options typically vest ratably over a three or four year period and expire 10 years from the grant date. Stock-based compensation expense for the fair value of the options at their grant date is recognized ratably over the vesting schedule for each separately vesting portion of the award. There were no stock options granted during the nine months ended March 31, 2017 or 2018. The table below presents stock option activity during the nine months ended March 31, 2018: Outstanding Options Weighted Weighted average average remaining Aggregate Number of exercise contractual intrinsic shares price term (years) value Balance at July 1, 2017 2,751 $ 11.54 5.69 $ 92,556 Options forfeited (5) $ 18.41 Options exercised (772) $ 9.28 Balance at March 31, 2018 1,974 $ 12.40 5.26 $ 76,638 Options exercisable at March 31, 2018 1,848 $ 11.23 5.15 $ 73,936 Options vested and expected to vest at March 31, 2018 1,970 $ 12.36 5.25 $ 76,563 The total intrinsic value of options exercised was $2,813 and $3,758 during the three months ended March 31, 2017 and 2018, respectively, and $8,352 and $31,013 during the nine months ended March 31, 2017 and 2018, respectively. At March 31, 2018, there was $262 of total unrecognized compensation cost, net of estimated forfeitures, related to unvested stock options granted under the Plan. That cost is expected to be recognized over a weighted average period of 0.90 years. The Company may also grant RSUs under the 2014 Plan with terms determined at the discretion of the compensation committee of the Company’s board of directors. RSUs generally vest over four years following the grant date. Certain RSU awards have time-based vesting conditions while other RSU awards are based on the achievement of certain revenue and Adjusted EBITDA targets in future fiscal years. The following table represents restricted stock unit activity during the nine months ended March 31, 2018: Units Weighted RSU balance at July 1, 2017 1,455 $ 39.96 RSUs granted 884 $ 45.95 RSUs vested (425) $ 39.31 RSUs forfeited (40) $ 41.73 RSU balance at March 31, 2018 1,874 $ 42.89 RSUs expected to vest at March 31, 2018 1,635 $ 42.69 At March 31, 2018, there was $34,872 of total unrecognized compensation cost, net of estimated forfeitures, related to unvested restricted stock units granted. That cost is expected to be recognized over a weighted average period of 1.86 years. (b) Employee Stock Purchase Plan Under the Company’s Employee Stock Purchase Plan (“ESPP”), the Company can grant stock purchase rights to all eligible employees during specific offering periods not to exceed twenty-seven months. Each offering period will begin on the trading day closest to May 16 and November 16 of each year. Shares are purchased through employees’ payroll deductions, up to a maximum of 10% of employees’ compensation for each purchase period, at a purchase price equal to 85% of the lesser of the fair market value of the Company’s common stock at the first trading day of the applicable offering period or the purchase date. Participants may purchase up to $25 worth of common stock or 2 shares of common stock in any one year. The ESPP is considered compensatory and results in compensation expense. As of March 31, 2018, a total of 1,166 shares of common stock were reserved for future issuances under the ESPP. The number of shares of common stock reserved for issuance under the ESPP will increase automatically each calendar year, continuing through and including January 1, 2024. The number of shares added each year will be equal to the lesser of (a) 400, (b) seventy-five one hundredths percent (0.75%) of the number of shares of common stock of the Company issued and outstanding on the immediately preceding December 31, or (c) an amount determined by the Company’s board of directors. The Company’s board of directors determined that, effective January 1, 2018, it would increase the number of common shares in reserve for issuance under the ESPP by 395 shares. The Company issued 53 shares upon the completion of its six-month offering period ending November 15, 2017. The Company recorded compensation expense attributable to the ESPP of $304 and $323 for the three months ended March 31, 2017 and 2018, respectively, and $967 and $971 for the nine months ended March 31, 2017 and 2018, respectively, which is included in the summary of stock-based compensation expense above. The grant date fair value of the ESPP offering periods was estimated using the following weighted average assumptions: Nine Months Ended March 31, 2017 2018 Valuation assumptions: Expected dividend yield % % Expected volatility 38.9 - 53.4 % 28.3 - 39.1 % Expected term (years) 0.5 0.5 Risk ‑ free interest rate 0.28 - 0.61 % 1.02 - 1.35 % (c) 401(k) Plan The Company maintains a 401(k) plan with a matching provision that covers all eligible employees. The Company matches 50% of employees’ contributions up to 8% of their gross pay. Contributions were $1,055 and $1,276 for the three months ended March 31, 2017 and 2018, respectively, and $2,732 and $3,382 for the nine months ended March 31, 2017 and 2018, respectively. |